Yao-Zhong Zhao
Overview
Explore the profile of Yao-Zhong Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao X, Dai Y, Zhao Y, Nie K
Front Pharmacol
. 2022 Apr;
13:855828.
PMID: 35462927
Gasdermin E (GSDME) is a member of the gasdermin protein family, which mediates programmed cell death including apoptosis and pyroptosis. Recently, it was suggested that GSDME is activated by chemotherapeutic...
2.
Zhao Y, Dai Y, Nie K
Front Pharmacol
. 2022 Feb;
12:790784.
PMID: 35222008
Chemotherapy-induced nausea and vomiting (CINV), a common side effect in antineoplastic treatment, dramatically decreases the quality of life as well as the compliance of cancer patients. Although numerous antiemetic agents...
3.
Mao X, Deng S, Sui W, Fu M, Liu J, Fan H, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2021 Jun;
29(3):812-818.
PMID: 34105477
Objective: To summarize and compare the clinical baseline characteristics of patients with monoclonal gammopathy of undetermined significance (MGUS), primary light chain amyloidosis (pAL), multiple myeloma (MM), or MM with concurrent...
4.
Mao X, Zhuang J, Zhao D, Li X, Du X, Hao M, et al.
Eur J Haematol
. 2020 May;
105(3):326-334.
PMID: 32421883
Background: In multiple myeloma (MM), impact of specific chromosomal translocations involving IgH (14q21 locus, including t(4;14), t(11;14), and t(14;16)) has been explored extensively. However, over 15% MM patients harboring IgH...
5.
Lin X, Hu H, Qian Y, Jie X, Nie B, Zhao Y, et al.
J Cosmet Dermatol
. 2020 Jan;
19(8):2125-2130.
PMID: 31930760
Background: Xanthelasma palpebrarum (XP) is the most common type of cutaneous xanthoma and has been treated with intralesional injection of pingyangmycin effectively. However, bleomycin, which has the same effect in...
6.
Qin X, An G, Li Z, Liu L, Xu Y, Yang L, et al.
Blood Adv
. 2019 Mar;
3(5):751-760.
PMID: 30833275
The treatment of multiple myeloma (MM) with proteasome inhibitor (PI) bortezomib has significantly improved the survival of patients with MM. The 26S proteasome inhibitor targets the unfolded protein response (UPR)...
7.
Zhang Y, Liu C, Qu C, Lu L, Liu A, Zhu L, et al.
World J Urol
. 2015 Apr;
33(12):2115-23.
PMID: 25910476
Purpose: Construction of a neourethra is always considered to be a difficult part in phalloplasty, especially for the female-to-male (FTM) transsexual patients. We report our experience with prefabricated pars pendulans...
8.
Liu C, Wei Z, Jiang H, Zhao Y, Zhang Y
Plast Reconstr Surg Glob Open
. 2014 Oct;
1(7):e53.
PMID: 25289248
We herein report a successful preconstruction of the pars pendulans urethrae with the ileum mucosa for phalloplasty in a one-arm patient using a prefabricated anterolateral thigh flap. After a 2-stage...
9.
Xing L, Xu Y, An G, Deng S, Sui W, Li F, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2013 Dec;
21(6):1492-5.
PMID: 24370035
This study was aimed to evaluate the prognostic value of serum IL-6 (sIL-6) in patients with multiple myeloma (MM). The sIL-6 level in 288 patients with MM was retrospectively analyzed,...
10.
Zhang Y, Qi J, Liu H, Liu W, Huang W, Deng S, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2013 Nov;
34(10):839-43.
PMID: 24171956
Objective: To investigate the clinical and laboratory characteristics and survival of Chinese patients with T- cell prolymphocytic leukemia (T-PLL). Methods: Eleven patients with T-PLL admitted in our hospital from Jan...